BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$33.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$25.1M
2
+$24.8M
3
+$9.33M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$6.5M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$6.41M

Top Sells

1
+$42.4M
2
+$31.3M
3
+$27.5M
4
OPTR
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
+$17.9M
5
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$15.7M

Sector Composition

1 Healthcare 87.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$343M 18.32%
4,058,542
+60,000
2
$266M 14.23%
3,547,714
-80,000
3
$256M 13.66%
6,417,548
-785,037
4
$214M 11.42%
4,221,087
-542,183
5
$104M 5.58%
1,404,445
6
$101M 5.38%
757,428
7
$94.4M 5.05%
2,959,412
+60,000
8
$70.8M 3.78%
4,724,936
-791,386
9
$67.3M 3.6%
636,542
+237,512
10
$55.6M 2.97%
858,757
+144,155
11
$52.8M 2.82%
192,000
+90,000
12
$47.3M 2.53%
3,225,816
-50,000
13
$31.7M 1.69%
1,102,311
14
$30.3M 1.62%
471,288
15
$29.4M 1.57%
488,188
+106,302
16
$28.2M 1.51%
2,643,522
+374,177
17
$24.7M 1.32%
2,646,552
+696,404
18
$18M 0.96%
1,300,737
19
$13.3M 0.71%
471,282
+97,982
20
$9.46M 0.51%
1,387,171
-2,301,900
21
$7.47M 0.4%
1,250,000
22
$5.91M 0.32%
1,779,340
23
– –
-1,422,200
24
– –
-339,870